Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001829126-21-002058
Filing Date
2021-03-31
Accepted
2021-03-31 16:23:56
Documents
69
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K inspyrtherap_10k.htm 10-K 921745
2 EXHIBIT 31.1 inspyrtherap_ex31-1.htm EX-31.1 7674
3 EXHIBIT 31.2 inspyrtherap_ex31-2.htm EX-31.2 7502
4 EXHIBIT 32.1 inspyrtherap_ex32-1.htm EX-32.1 5738
5 EXHIBIT 32.2 inspyrtherap_ex32-2.htm EX-32.2 6453
  Complete submission text file 0001829126-21-002058.txt   3845173

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE nspx-20201231.xml EX-101.INS 519866
7 XBRL SCHEMA FILE nspx-20201231.xsd EX-101.SCH 44552
8 XBRL CALCULATION FILE nspx-20201231_cal.xml EX-101.CAL 42842
9 XBRL DEFINITION FILE nspx-20201231_def.xml EX-101.DEF 176756
10 XBRL LABEL FILE nspx-20201231_lab.xml EX-101.LAB 306995
11 XBRL PRESENTATION FILE nspx-20201231_pre.xml EX-101.PRE 254770
Mailing Address 2629 TOWNSGATE RD, SUITE 215 WESTLAKE VILLAGE CA 91361
Business Address 2629 TOWNSGATE RD, SUITE 215 WESTLAKE VILLAGE CA 91361 (210) 479-8112
Inspyr Therapeutics, Inc. (Filer) CIK: 0001421204 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-55331 | Film No.: 21793669
SIC: 2834 Pharmaceutical Preparations